Department of Medical Genetics, Bahcesehir University School of Medicine, Istanbul, Turkey.
Clin Endocrinol (Oxf). 2013 Aug;79(2):275-81. doi: 10.1111/cen.12127. Epub 2013 May 6.
In this study, we aimed to investigate the genetic background of thyroid dyshormonogenesis (TDH).
Thyroid dyshormonogenesis comprises 10-15% of all cases of congenital hypothyroidism (CH), which is the most common neonatal endocrine disorder, and might result from disruptions at any stage of thyroid hormone biosynthesis. Currently seven genes (NIS, TPO, PDS, TG, IYD, DUOX2 and DUOXA2) have been implicated in the aetiology of the disease.
As TDH is mostly inherited in an autosomal recessive manner, we planned to conduct the study in consanguineous/multi-case families.
One hundred and four patients with congenital TDH all coming from consanguineous and/or multi-case families.
Initially, we performed potential linkage analysis of cases to all seven causative-TDH loci as well as direct sequencing of the TPO gene in cases we could not exclude linkage to this locus. In addition, in silico analyses of novel missense mutations were carried out.
TPO had the highest potential for linkage and we identified 21 TPO mutations in 28 TDH cases showing potential linkage to this locus. Four of 10 distinct TPO mutations detected in this study were novel (A5T, Y55X, E596X, D633N).
This study underlines the importance of molecular genetic studies in diagnosis, classification and prognosis of CH and proposes a comprehensive mutation screening by new sequencing technology in all newly diagnosed primary CH cases.
本研究旨在探讨甲状腺激素生物合成障碍(TDH)的遗传背景。
TDH 占所有先天性甲状腺功能减退症(CH)病例的 10-15%,是最常见的新生儿内分泌疾病,可能由甲状腺激素生物合成的任何阶段的中断引起。目前已有 7 个基因(NIS、TPO、PDS、TG、IYD、DUOX2 和 DUOXA2)与该病的病因有关。
由于 TDH 主要以常染色体隐性方式遗传,我们计划在近亲/多病例家庭中进行研究。
104 例先天性 TDH 患者均来自近亲/多病例家庭。
最初,我们对病例进行了潜在的连锁分析,以确定与所有 7 个致 TDH 基因座的相关性,并对我们无法排除与该基因座相关性的病例进行 TPO 基因的直接测序。此外,还进行了新错义突变的计算机分析。
TPO 具有最高的连锁潜力,我们在 28 例显示与该基因座潜在连锁的 TDH 病例中发现了 21 个 TPO 突变。本研究中检测到的 10 种不同的 TPO 突变中有 4 种是新的(A5T、Y55X、E596X、D633N)。
本研究强调了分子遗传学研究在 CH 的诊断、分类和预后中的重要性,并提出了在所有新诊断的原发性 CH 病例中应用新测序技术进行全面突变筛查的建议。